M. Hérasse

发表

Severe hypophosphatasia: Characterization of fifteen novel mutations in the ALPL gene

S. Mansour, S. Holder, A. Norman, 2003, Human mutation.

Calpain 3 mRNA expression in mice after denervation and during muscle regeneration.

J. Beckmann, I. Richard, D. Stockholm, 2001, American journal of physiology. Cell physiology.

Development of a Prediction Model for COVID‐19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry

M. Gianfrancesco, J. Yazdany, G. Schmajuk, 2022, ACR open rheumatology.

Research Article Alteration of Sarcoplasmic Reticulum Ca 2+ Release in Skeletal Muscle from Calpain 3-Deficient Mice

N. Bourg, I. Richard, P. Mangeat, 2009 .

Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy.

N. Romero, J. Chiras, P. Laforêt, 2006, Brain : a journal of neurology.

Alteration of Sarcoplasmic Reticulum Ca2+ Release in Skeletal Muscle from Calpain 3-Deficient Mice

C. Viero, G. Lefranc, N. Bourg, 2010, International journal of cell biology.

Molecular study of three cases of odontohypophosphatasia resulting from heterozygosity for mutations in the tissue non-specific alkaline phosphatase gene

K. Keppler-Noreuil, J. Bergoffen, R. Wallerstein, 2003, Journal of medical genetics.

Evidence of a founder effect for the tissue-nonspecific alkaline phosphatase (TNSALP) gene E174K mutation in hypophosphatasia patients

E. Mornet, M. Spentchian, M. Hérasse, 2002, European Journal of Human Genetics.

Expression and Functional Characteristics of Calpain 3 Isoforms Generated through Tissue-Specific Transcriptional and Posttranscriptional Events

J. Beckmann, F. Fougerousse, H. Sorimachi, 1999, Molecular and Cellular Biology.

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Julie M. Woessner, P. Hennequin, Cécile Paris, 2021, The Lancet Rheumatology.

Muscle imaging in dominant core myopathies linked or unlinked to the ryanodine receptor 1 gene

N. Romero, J. Chiras, L. Viollet, 2006, Neurology.

Human-mouse differences in the embryonic expression patterns of developmental control genes and disease genes.

J. Beckmann, T. Strachan, S. Lindsay, 2000, Human molecular genetics.

Stable expression of calpain 3 from a muscle transgene in vivo: Immature muscle in transgenic mice suggests a role for calpain 3 in muscle maturation

J. Beckmann, L. Kunkel, I. Richard, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Loss of Calpain 3 Proteolytic Activity Leads to Muscular Dystrophy and to Apoptosis-Associated Iκbα/Nuclear Factor κb Pathway Perturbation in Mice

J. Beckmann, G. Lefranc, N. Bourg, 2000, The Journal of cell biology.

Abnormal Distribution of Calcium-Handling Proteins: A Novel Distinctive Marker in Core Myopathies

K. Parain, N. Romero, J. Leroy, 2007, Journal of neuropathology and experimental neurology.

Loss of Calpain 3 Proteolytic Activity Leads to Muscular Dystrophy and to Apoptosis-Associated Iκbα/Nuclear Factor κb Pathway Perturbation in Mice

J. Beckmann, G. Lefranc, N. Bourg, 2000, The Journal of cell biology.

Clinical and histopathological aspects of central core disease associated and non-associated with RYR1 locus.

N. Romero, L. Viollet, P. Laforêt, 2005, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.